Tuula Kallunki
0000-0002-8571-383X
Publication & Citation Trends
Publications
0 total
Abstract 530: A personalized HGSC organoid platform for repurposing lysosomal death inducing drugs
Cited by 0
Semantic Scholar
Abstract 4249: Establishment and analysis of patient-derived high-grade serous ovarian cancer organoids for disease modeling and drug testing
Cited by 2
Semantic Scholar
Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers OA
Cited by 13
Semantic Scholar
#252 Evolutionary study identifies poor prognosis HGSC patients and reveals clinically relevant targets at diagnosis and relapse OA
Cited by 0
Semantic Scholar
Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis OA
Cited by 21
Semantic Scholar
EVOLUTIONARY STUDY IDENTIFIES POOR PROGNOSIS HGSC PATIENTS AND REVEALS CLINICALLY RELEVANT TARGETS AT DIAGNOSIS AND RELAPSE
Cited by 0
Semantic Scholar
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis OA
Cited by 0
Semantic Scholar
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma. OA
Cited by 36
Semantic Scholar
Research Topics
Melanoma and MAPK Pathways
(14)
Cell Adhesion Molecules Research
(12)
Cytokine Signaling Pathways and Interactions
(9)
Calcium signaling and nucleotide metabolism
(9)
Cell death mechanisms and regulation
(8)
Affiliations
University of Copenhagen
University of San Diego
University of California, San Diego
Biocenter Finland
Danish Cancer Society